| Date | Title | Description |
| 20.03.2024 | Synthace Announces Appointment of Willem Baralt as New Chairman | LONDON and BOSTON, March 20, 2024 /PRNewswire/ -- Synthace, the leading digital experiment platform for life science R&D, today announced the appointment of Willem Baralt as its new Chairman of the Board. Mr. Baralt joined the company i... |
| 28.05.2023 | Weekly AiThority Roundup: Biggest Machine Learning, Robotic And Automation Updates – May 4th Week | This is your AI Weekly Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human... |
| 24.05.2023 | Synthace Combines ChatGPT And Digital Experiments In First Step Toward A True AI Scientist | Synthace, creators of the world’s first digital experiment platform for life science R&D, announces the successful integration of their platform with OpenAI’s ChatGPT. This revolutionary development lets scientists use a natural languag... |
| 16.11.2021 | Casper turns painful even for some of its earliest startup investors | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Even if a startup takes a cut to its valuation, it’s completely possible that investors who took ... |
| 16.11.2021 | Synthace Raises $35M in Series C Funding | Synthace, a London, UK-based life sciences software company enabling scientists to automate biology experimentation and insight sharing in a unified, global R&D environment, raised $35m in Series C funding.
The round was co-led by Horiz... |
| 16.11.2021 | Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research | Synthace, the first life sciences software company to enable scientists to automate biology experimentation and insight sharing in a unified, global R&D environment today announced it raised $35 million in Series C funding. The investme... |
| 16.11.2021 | Synthace raises $35M Series C to accelerate the development of cures and expand reach | Credit: Synthace |
| 11.08.2021 | Why Is Science Still On Spreadsheets? Meet The Company Moving Biology Into The Cloud | Digitized, cloud-based biology could significantly increase the reproducibility and speed of biology ... [+] innovation.Pixabay |
| 02.08.2021 | Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility For Scientists | First Ever No-Code Platform Lowers Barriers to Automated Biological Experimentation and Insight Sharing
Synthace, a leading life sciences software company, announced the first life sciences R&D cloud that includes a no-code software pla... |
| 15.04.2021 | Building Digitally Empowered Bioprocess Development Organizations to Accelerate Product Release, Upcoming Webinar Hosted by Xtalks | Having experienced the effects of reduced on-site access, the urgency for pharmaceutical and biotech companies to implement digital tools and platforms to support R&D has never been higher.
TORONTO (PRWEB) April 15, 2021
The global pand... |
| 09.03.2021 | Synthace Appoints Dr. Nick Jurascheck as VP of Engineering | LONDON--(BUSINESS WIRE)--Mar 9, 2021--
Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, today announced the appointment of Nick Jurascheck as VP... |
| 27.09.2019 | How To Spot A Synthetic Biology Unicorn | Biotech is projected to reach $775 billion by 2024, but dozens of companies in the field of ... [+] synthetic biology are creating magical tools to go beyond that. Look here for the next unicorn. Jelena Trmčić for SynBioBeta |
| 17.12.2018 | Synthace secures $25.6 million in Series B funding | Synthace Ltd, the company behind a cloud software platform for automating and improving the success rate of biological research and development, has closed a $25.6m Series B financing round.
The funding was led by Horizons Ventures with add... |
| 16.12.2018 | HK-based Horizons Ventures invests $26m in UK’s bio-research firm Synthace | Premium
London-based Synthace Ltd, a cloud-based platform that helps improve the success rate of biological research, has closed a $25.6-million Series B financing round led by Hong Kong-based Horizons Ventures, the private investment arm o... |
| 16.12.2018 | Luminous Ventures Joins $25.6M Series B for Synthace | Synthace Ltd., the company behind the leading cloud software platform for automating and improving the success rate of biological research and development, today announced the closing of a $25.6m Series B financing round led by Horizons Ven... |
| 14.12.2018 | Term Sheet — Friday, December 14 | THE RISE OF THE FAMILY OFFICE
While no one was looking, family offices have transformed into financial titans.
Paid Content You can't secure what you can't see From ExtraHop
Family offices control $4 trillion of assets, which is more than h... |
| 13.12.2018 | Synthace Raises $25.6M in Series B Funding | Synthace Ltd., a London, UK-based provider of a cloud software platform for automating and improving the success rate of biological research and development, closed a $25.6m Series B financing.
The round was led by Horizons Ventures with pa... |
| 12.12.2018 | Synthace raises $25.6 million to automate bio labs with software | U.K.-based startup Synthace wants to automate laboratory processes with a programming language designed for biological experiments, and it’s getting the financial backing to do it.
The company today announced that it’s raised $25.6 million ... |
| 12.12.2018 | Synthace raises $25.6 million to automate bio labs with software | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
U.K.-based startup Synthace wants to automate laboratory processes with a programming language designed for biological experiments, and... |
| 25.09.2017 | Term Sheet — Monday, September 25 | ELON MUSK STRIKES AGAIN
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
UBER’S SOFT SIDE: Across the ocean, Uber began its morning with an apology to British regulators after the ride-... |
| 25.09.2017 | Synthace raises a £7.3m Series A to bring open source to biotech | Synthace, a UK startup using open source technology to make process in biotechnology move faster, has raises a £7.3m Series A round. New investors White Cloud Capital, Amadeus Capital Partners and Eleven Two Capital participated alongside e... |
| 21.09.2017 | Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs | Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
21-09-2017
Synthace Ltd., the technology company behind the Antha operating system for biology, announced that it has raised £7.3m ($9.6m) in Series A funding.... |
| 21.09.2017 | Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs | Synthace Ltd., the technology company behind the Antha operating system for biology, announced that it has raised £7.3m ($9.6m) in Series A funding. White Cloud Capital, Amadeus Capital Partners and Eleven Two Capital participated in the ro... |
| 20.09.2017 | Term Sheet — Wednesday, September 20 | THE ROBOTS ARE COMING
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
It is so massive—its investors range from a Saudi sovereign wealth fund to Apple—that small stakes are impossible ... |
| 19.09.2017 | Synthace Raises £7.3m in Series A Funding | Synthace Ltd., the London, UK-based technology company behind the Antha operating system for biology, raised £7.3m ($9.6m) in Series A funding.
Backers included Cloud Capital, Amadeus Capital Partners and Eleven Two Capital and existing sha... |
| 28.01.2016 | 30 of The UK’s Finest Early Stage Tech Businesses Selected to Join Upscale | This article was originally posted on the Tech City UK website.
Today we’re announcing the first 30 companies to join Upscale. The Upscale programme from Tech City UK will power 30 of the fastest growing UK tech companies on their scaling ... |
| 24.09.2013 | Synthace Raises £1.3M | Synthace, a London, UK-based applied synthetic biology company developing high value chemical and biological products, closed a £1.3m funding round.
The round was led by Sofinnova Partners’ Green Seed Fund, with participation from a syndica... |
| - | Synthace raises $35 million, helps scientists automate biology experimentation and insight sharing | London’s Synthace has raised $35 million in a Series C funding round. The life sciences company provides an R&D cloud platform that gives scientists around the globe the ability to automate biology experimentation and insight sharing. T... |
